Could Pfizer Be Dragged Into EU’s Vaccine Dispute With AstraZeneca and UK?
Reprisals Against UK Not Ruled Out
The European Commission is once again threatening to block exports of COVID-19 vaccines to the UK – including those from Pfizer/BioNTech.
You may also be interested in...
The procurement and authorization of vaccines are under scrutiny in the European Parliament this week. In the meantime, another Sputnik V spat is taking wing between Russia and the EU, while France has resumed the use of AstraZeneca’s vaccine, but only in the over-55s.
The EMA’s conclusions are in line with those of the UK regulator and the World Health Organization, but EU countries’ stop-start decisions will have done nothing to boost the public’s trust in the vaccine.
The venture capital firm is putting $210m into NSCLC trials for the antibody drug conjugate – with an opportunity in patients who fail on first line immunotherapy the most likely target.